Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs, Expert Review of Pharmacoeconomics & Outcomes Research, April 2018, Taylor & Francis, DOI: 10.1080/14737167.2018.1467270.
You can read the full text:
Be the first to contribute to this page